Lunai Bioworks (LNAI) Gross Profit (2013 - 2026)

Lunai Bioworks (LNAI) posted quarterly Gross Profit of $20942.0 for Q1 2026, up 9731.92% quarter-over-quarter from $213.0 in Q2 2016.

Lunai Bioworks (LNAI) Gross Profit (2013 - 2026) Analysis & Trends

Lunai Bioworks' Gross Profit history runs 5 years deep, the most recent figure standing at $20942.0 for Q1 2026.

In Q1 2026, Gross Profit changed N/A year-over-year to $20942.0; the TTM figure through Mar 2026 stood at -$450779.0 (changed N/A YoY), while the FY2016 annual figure was $37494.0, up 156.87% from the prior year.
Gross Profit for Q1 2026 stood at $20942.0, up from $213.0 in the prior quarter.
The five-year high for Gross Profit was $20942.0 in Q1 2026, with the low at $20942.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Lunai Bioworks	6.87 Mn	3.72 Mn	20,942.00

Download Data